David M. Warshaw
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
David M. Warshaw has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
Michael J. Previs
Department of Molecular Physiology and Biophysics, University of Vermont, Burlington, VT 05405
8 shared publicationsSamantha Beck Previs
Department of Molecular Physiology and Biophysics, University of Vermont, Burlington, VT 05405
8 shared publicationsJames Gulick
Division of Molecular Cardiovascular Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229
7 shared publicationsJeffrey Robbins
Division of Molecular Cardiovascular Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229
6 shared publicationsArthur J. Michalek
Department of Molecular Physiology and Biophysics, Cardiovascular Research Institute, University of Vermont, Burlington, VT 05405
4 shared publicationsJi Young Mun
Department of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, MA 01655
4 shared publications
Latest Publications
- 1 August 2020
- Published by Elsevier in Biophysical Journal
- Vol. 119 (4) , 806-820
Mechanical Characteristics of Ultrafast Zebrafish Larval Swimming Muscles
- 1 August 2020
- Published by Elsevier in Biophysical Journal
- Vol. 119 (4) , 806-820
Mechanical Characteristics of Ultrafast Zebrafish Larval Swimming Muscles
- Open Access
- 15 March 2019
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 116 (14) , 6828-6835
Revealing the mechanism of how cardiac myosin-binding protein C N-terminal fragments sensitize thin filaments for myosin binding
Significance: Diverse demands on cardiac muscle require the fine-tuning of contraction. Cardiac myosin binding protein-C (cMyBP-C) is involved in this regulation; however, its precise molecular mechanism of action remains uncertain. By imaging the interactions of single myosin and cMyBP-C molecules interacting with suspended thin filaments in vitro we observe cMyBP-C N-terminal fragments assist activation and modulate contraction velocity by affecting myosin binding to the thin filament. Fluorescent imaging of Cy3-labeled cMyBP-C revealed that it diffusively scans the thin filament and then strongly binds to displace tropomyosin and activate at low calcium. At high calcium, cMyBP-C decorates the filament more extensively, reducing myosin binding through competing with binding sites. Understanding the mechanism of MyBP-C action has important implications for heart disease.
- 15 March 2019
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 116 (14) , 6828-6835
Open AccessRevealing the mechanism of how cardiac myosin-binding protein C N-terminal fragments sensitize thin filaments for myosin binding
Significance: Diverse demands on cardiac muscle require the fine-tuning of contraction. Cardiac myosin binding protein-C (cMyBP-C) is involved in this regulation; however, its precise molecular mechanism of action remains uncertain. By imaging the interactions of single myosin and cMyBP-C molecules interacting with suspended thin filaments in vitro we observe cMyBP-C N-terminal fragments assist activation and modulate contraction velocity by affecting myosin binding to the thin filament. Fluorescent imaging of Cy3-labeled cMyBP-C revealed that it diffusively scans the thin filament and then strongly binds to displace tropomyosin and activate at low calcium. At high calcium, cMyBP-C decorates the filament more extensively, reducing myosin binding through competing with binding sites. Understanding the mechanism of MyBP-C action has important implications for heart disease.
- Open Access
- 18 October 2018
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 3 (20)
Diabetes with heart failure increases methylglyoxal modifications in the sarcomere, which inhibit function
Patients with diabetes are at significantly higher risk of developing heart failure. Increases in advanced glycation end products are a proposed pathophysiological link, but their impact and mechanism remain incompletely understood. Methylglyoxal (MG) is a glycolysis byproduct, elevated in diabetes, and modifies arginine and lysine residues. We show that left ventricular myofilament from patients with diabetes and heart failure (dbHF) exhibited increased MG modifications compared with nonfailing controls (NF) or heart failure patients without diabetes. In skinned NF human and mouse cardiomyocytes, acute MG treatment depressed both calcium sensitivity and maximal calcium-activated force in a dose-dependent manner. Importantly, dbHF myocytes were resistant to myofilament functional changes from MG treatment, indicating that myofilaments from dbHF patients already had depressed function arising from MG modifications. In human dbHF and MG-treated mice, mass spectrometry identified increased MG modifications on actin and myosin. Cosedimentation and in vitro motility assays indicate that MG modifications on actin and myosin independently depress calcium sensitivity, and mechanistically, the functional consequence requires actin/myosin interaction with thin-filament regulatory proteins. MG modification of the myofilament may represent a critical mechanism by which diabetes induces heart failure, as well as a therapeutic target to avoid the development of or ameliorate heart failure in these patients.
- 18 October 2018
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 3 (20)
Open AccessDiabetes with heart failure increases methylglyoxal modifications in the sarcomere, which inhibit function
Patients with diabetes are at significantly higher risk of developing heart failure. Increases in advanced glycation end products are a proposed pathophysiological link, but their impact and mechanism remain incompletely understood. Methylglyoxal (MG) is a glycolysis byproduct, elevated in diabetes, and modifies arginine and lysine residues. We show that left ventricular myofilament from patients with diabetes and heart failure (dbHF) exhibited increased MG modifications compared with nonfailing controls (NF) or heart failure patients without diabetes. In skinned NF human and mouse cardiomyocytes, acute MG treatment depressed both calcium sensitivity and maximal calcium-activated force in a dose-dependent manner. Importantly, dbHF myocytes were resistant to myofilament functional changes from MG treatment, indicating that myofilaments from dbHF patients already had depressed function arising from MG modifications. In human dbHF and MG-treated mice, mass spectrometry identified increased MG modifications on actin and myosin. Cosedimentation and in vitro motility assays indicate that MG modifications on actin and myosin independently depress calcium sensitivity, and mechanistically, the functional consequence requires actin/myosin interaction with thin-filament regulatory proteins. MG modification of the myofilament may represent a critical mechanism by which diabetes induces heart failure, as well as a therapeutic target to avoid the development of or ameliorate heart failure in these patients.
- Open Access
- 1 July 2016
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 27 (13) , 2080-2089
Dense granule trafficking inToxoplasma gondiirequires a unique class 27 myosin and actin filaments
Toxoplasma gondii survival within its host cell requires protein release from secretory vesicles, called dense granules (DGs), in order to maintain the parasite's intracellular replicative niche. Despite their importance, nothing is known about the mechanisms underlying DG transport. In higher eukaryotes, secretory vesicles are transported to the plasma membrane by molecular motors moving on their respective cytoskeletal tracks (i.e. microtubules and actin). Since the organization of these cytoskeletal structures differs substantially in Toxoplasma gondii, the molecular motor-dependence of DG trafficking is far from certain. By imaging the motions of GFP-tagged DGs in intracellular parasites with high temporal and spatial resolution, we show through a combination of molecular genetics and chemical perturbations that directed DG transport is independent of microtubules and presumably their kinesin/dynein motors. However, directed DG transport is dependent on filamentous actin and a unique class 27 myosin, TgMyoF, which has structural similarity to myosin V, the prototypical cargo transporter. Acto-myosin DG transport was unexpected since filamentous parasite actin has yet to be visualized in vivo due in part to the prevailing model that parasite actin forms short, unstable filaments. Thus, our data uncover new critical roles for these essential proteins in the lytic cycle of this devastating pathogen.
- 1 July 2016
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 27 (13) , 2080-2089
Open AccessDense granule trafficking inToxoplasma gondiirequires a unique class 27 myosin and actin filaments
Toxoplasma gondii survival within its host cell requires protein release from secretory vesicles, called dense granules (DGs), in order to maintain the parasite's intracellular replicative niche. Despite their importance, nothing is known about the mechanisms underlying DG transport. In higher eukaryotes, secretory vesicles are transported to the plasma membrane by molecular motors moving on their respective cytoskeletal tracks (i.e. microtubules and actin). Since the organization of these cytoskeletal structures differs substantially in Toxoplasma gondii, the molecular motor-dependence of DG trafficking is far from certain. By imaging the motions of GFP-tagged DGs in intracellular parasites with high temporal and spatial resolution, we show through a combination of molecular genetics and chemical perturbations that directed DG transport is independent of microtubules and presumably their kinesin/dynein motors. However, directed DG transport is dependent on filamentous actin and a unique class 27 myosin, TgMyoF, which has structural similarity to myosin V, the prototypical cargo transporter. Acto-myosin DG transport was unexpected since filamentous parasite actin has yet to be visualized in vivo due in part to the prevailing model that parasite actin forms short, unstable filaments. Thus, our data uncover new critical roles for these essential proteins in the lytic cycle of this devastating pathogen.
- 23 February 2016
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 113 (12) , 3239-3244
Phosphorylation and calcium antagonistically tune myosin-binding protein C’s structure and function
Significance: Mutations in cardiac myosin-binding protein C (cMyBP-C) are the leading cause of inherited hypertrophic cardiomyopathy, demonstrating the key role that cMyBP-C plays in the heart’s contractile machinery. Since its discovery >40 years ago, cardiovascular biologists have wondered how cMyBP C’s structure regulates its function. Using atomic force spectroscopy, electron microscopy, in vitro model systems of contractility, and mutant protein expression, we show how phosphorylation affects cMyBP-C’s structure to tune its functions within the contractile apparatus. We also identify a novel molecular mechanism by which calcium ions that trigger each muscle contraction override phosphorylation’s structural and functional impact. This intersection of posttranslational modification and calcium signaling may occur in other biological systems that rely on these pathways to control cellular processes.
- 23 February 2016
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 113 (12) , 3239-3244
Phosphorylation and calcium antagonistically tune myosin-binding protein C’s structure and function
Significance: Mutations in cardiac myosin-binding protein C (cMyBP-C) are the leading cause of inherited hypertrophic cardiomyopathy, demonstrating the key role that cMyBP-C plays in the heart’s contractile machinery. Since its discovery >40 years ago, cardiovascular biologists have wondered how cMyBP C’s structure regulates its function. Using atomic force spectroscopy, electron microscopy, in vitro model systems of contractility, and mutant protein expression, we show how phosphorylation affects cMyBP-C’s structure to tune its functions within the contractile apparatus. We also identify a novel molecular mechanism by which calcium ions that trigger each muscle contraction override phosphorylation’s structural and functional impact. This intersection of posttranslational modification and calcium signaling may occur in other biological systems that rely on these pathways to control cellular processes.
- Open Access
- 6 February 2015
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 1 (1) , e1400205
Myosin-binding protein C corrects an intrinsic inhomogeneity in cardiac excitation-contraction coupling
The localization of MyBP-C within cardiac muscle cells provides efficient mechanochemical excitation-contraction coupling.
- 6 February 2015
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 1 (1) , e1400205
Open AccessMyosin-binding protein C corrects an intrinsic inhomogeneity in cardiac excitation-contraction coupling
The localization of MyBP-C within cardiac muscle cells provides efficient mechanochemical excitation-contraction coupling.
- 1 January 2015
- Published by Elsevier in Biophysical Journal
- Vol. 108 (2) , 362a
Myosin-Binding Protein C Corrects an Intrinsic Non-Uniformity in Cardiac Excitation-Contraction Coupling
- 1 January 2015
- Published by Elsevier in Biophysical Journal
- Vol. 108 (2) , 362a
Myosin-Binding Protein C Corrects an Intrinsic Non-Uniformity in Cardiac Excitation-Contraction Coupling
- Open Access
- 13 October 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (10) , e109082
Cytoskeletal Dependence of Insulin Granule Movement Dynamics in INS-1 Beta-Cells in Response to Glucose
For pancreatic β-cells to secrete insulin in response to elevated blood glucose, insulin granules retained within the subplasmalemmal space must be transported to sites of secretion on the plasma membrane. Using a combination of super-resolution STORM imaging and live cell TIRF microscopy we investigate how the organization and dynamics of the actin and microtubule cytoskeletons in INS-1 β-cells contribute to this process. GFP-labeled insulin granules display 3 different modes of motion (stationary, diffusive-like, and directed). Diffusive-like motion dominates in basal, low glucose conditions. Upon glucose stimulation no gross rearrangement of the actin cytoskeleton is observed but there are increases in the 1) rate of microtubule polymerization; 2) rate of diffusive-like motion; and 3) proportion of granules undergoing microtubule-based directed motion. By pharmacologically perturbing the actin and microtubule cytoskeletons, we determine that microtubule-dependent granule transport occurs within the subplasmalemmal space and that the actin cytoskeleton limits this transport in basal conditions, when insulin secretion needs to be inhibited.
- 13 October 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (10) , e109082
Open AccessCytoskeletal Dependence of Insulin Granule Movement Dynamics in INS-1 Beta-Cells in Response to Glucose
For pancreatic β-cells to secrete insulin in response to elevated blood glucose, insulin granules retained within the subplasmalemmal space must be transported to sites of secretion on the plasma membrane. Using a combination of super-resolution STORM imaging and live cell TIRF microscopy we investigate how the organization and dynamics of the actin and microtubule cytoskeletons in INS-1 β-cells contribute to this process. GFP-labeled insulin granules display 3 different modes of motion (stationary, diffusive-like, and directed). Diffusive-like motion dominates in basal, low glucose conditions. Upon glucose stimulation no gross rearrangement of the actin cytoskeleton is observed but there are increases in the 1) rate of microtubule polymerization; 2) rate of diffusive-like motion; and 3) proportion of granules undergoing microtubule-based directed motion. By pharmacologically perturbing the actin and microtubule cytoskeletons, we determine that microtubule-dependent granule transport occurs within the subplasmalemmal space and that the actin cytoskeleton limits this transport in basal conditions, when insulin secretion needs to be inhibited.
- 8 September 2014
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 111 (38) , E3986-E3995
Motor coupling through lipid membranes enhances transport velocities for ensembles of myosin Va
Significance: Intracellular cargo transport is carried out by ensembles of cytoskeleton-based molecular motors, such as myosin Va. Physiologically, motor molecules are bound to (and mechanically coupled through) the vesicular membrane, which is a fluid lipid bilayer. Utilizing a combination of experiment and computer simulation, we characterize the influence of three distinct aspects of the vesicular ensemble (vesicle size, membrane composition, and motor density) on cargo transport. We also demonstrate the presence of vesicle populations that travel at velocities up to twice the unloaded velocity of a single motor. These findings serve to bridge the gap between enhanced vesicular velocities measured in vivo and depressed velocities measured in vitro.
- 8 September 2014
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 111 (38) , E3986-E3995
Motor coupling through lipid membranes enhances transport velocities for ensembles of myosin Va
Significance: Intracellular cargo transport is carried out by ensembles of cytoskeleton-based molecular motors, such as myosin Va. Physiologically, motor molecules are bound to (and mechanically coupled through) the vesicular membrane, which is a fluid lipid bilayer. Utilizing a combination of experiment and computer simulation, we characterize the influence of three distinct aspects of the vesicular ensemble (vesicle size, membrane composition, and motor density) on cargo transport. We also demonstrate the presence of vesicle populations that travel at velocities up to twice the unloaded velocity of a single motor. These findings serve to bridge the gap between enhanced vesicular velocities measured in vivo and depressed velocities measured in vitro.
- 1 August 2014
- Published by Elsevier in DNA Repair
- Vol. 20, 23-31
Insights into the glycosylase search for damage from single-molecule fluorescence microscopy
- 1 August 2014
- Published by Elsevier in DNA Repair
- Vol. 20, 23-31
Insights into the glycosylase search for damage from single-molecule fluorescence microscopy